Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larissa Lapteva

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 26, 2016
Investigational New Drug applications: a 1-year pilot study on rates and reasons for clinical holdLarissa Lapteva, Anne R Pariser
Translational Science of Rare Diseases|January 8, 2019
Regenerative Medicine Therapies for Rare DiseasesLarissa Lapteva, Ramjay Vatsan, Tejashri Purohit-Sheth
Molecular Therapy. Methods & Clinical Development|November 19, 2020
Clinical Development of Gene Therapies: The First Three Decades and CountingLarissa Lapteva, Tejashri Purohit-Sheth, Mercedes Serabian, et al.
JAMA Pediatrics|June 30, 2020
Gene and Stem Cell Therapies for Fetal Care: A ReviewAmy E O'Connell, Stephanie Guseh, Larissa Lapteva, et al.
Arthritis and Rheumatism|June 2, 2006
Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosusTresa M Roebuck-Spencer, Cheryl Yarboro, Miroslawa Nowak, et al.
Journal of Clinical Pharmacology|September 15, 2022
Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI-FDA Meeting)Akos Herzeg, Graça Almeida-Porada, R Alta Charo, et al.
Therapeutic Advances in Rare Disease|May 29, 2025
From roadmap to a sustainable end-to-end individualized therapy pathwayAnneliene H Jonker, Elena-Alexandra Tataru, David P Dimmock, et al.
Arthritis and Rheumatism|July 27, 2006
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosusLarissa Lapteva, Miroslawa Nowak, Cheryl H Yarboro, et al.
Nature Reviews. Drug Discovery|November 4, 2024
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmapAnneliene H Jonker, Elena-Alexandra Tataru, Holm Graessner, et al.
Seminars in Arthritis and Rheumatism|July 23, 2022
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefitJason S Kim, Silvana Borges, Daniel J Clauw, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 26, 2016
Investigational New Drug applications: a 1-year pilot study on rates and reasons for clinical holdLarissa Lapteva, Anne R Pariser
Translational Science of Rare Diseases|January 8, 2019
Regenerative Medicine Therapies for Rare DiseasesLarissa Lapteva, Ramjay Vatsan, Tejashri Purohit-Sheth
Molecular Therapy. Methods & Clinical Development|November 19, 2020
Clinical Development of Gene Therapies: The First Three Decades and CountingLarissa Lapteva, Tejashri Purohit-Sheth, Mercedes Serabian, et al.
JAMA Pediatrics|June 30, 2020
Gene and Stem Cell Therapies for Fetal Care: A ReviewAmy E O'Connell, Stephanie Guseh, Larissa Lapteva, et al.
Arthritis and Rheumatism|June 2, 2006
Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosusTresa M Roebuck-Spencer, Cheryl Yarboro, Miroslawa Nowak, et al.
Journal of Clinical Pharmacology|September 15, 2022
Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI-FDA Meeting)Akos Herzeg, Graça Almeida-Porada, R Alta Charo, et al.
Therapeutic Advances in Rare Disease|May 29, 2025
From roadmap to a sustainable end-to-end individualized therapy pathwayAnneliene H Jonker, Elena-Alexandra Tataru, David P Dimmock, et al.
Arthritis and Rheumatism|July 27, 2006
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosusLarissa Lapteva, Miroslawa Nowak, Cheryl H Yarboro, et al.
Nature Reviews. Drug Discovery|November 4, 2024
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmapAnneliene H Jonker, Elena-Alexandra Tataru, Holm Graessner, et al.
Seminars in Arthritis and Rheumatism|July 23, 2022
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefitJason S Kim, Silvana Borges, Daniel J Clauw, et al.
Pageof 1